miR-2682-3p antagonizes its host lncRNA-MIR137HG by interacting with the same target FUS to regulate the progression of gastric cancer

Table 1 Clinical features of MIR137HG expression in gastric cancer samples and paired surgical margin samples

Clinical features	Classic	Case no	GC Expression Median[25%-75%]	P-value	SM Expression Median[25%-75%]	P-value
Age (Years)	≤ 60	23	0.036 [0.002–1.743]	0.556	0.162 [0.005–1.735]	0.603
Age (Years)	> 60	46	0.097 [0.006–6.897]		0.109 [0.014–1.808]
Sex	Male	53	0.107 [0.006–2.962]	0.039*	0.504 [0.045–3.321]	0.388
Sex	Female	16	0.048 [0.003–6.071]		0.135 [0.009–1.706]
Differentiation	Poor	53	0.095 [0.005–5.610]	0.676	0.239 [0.024–2.318]	0.003*
Differentiation	Moderate/ Well	16	0.024 [0.004–2.833]		0.034 [0.002–0.720]
Vascular emblus	No	27	0.228 [0.018–11.426]	0.781	0.560 [0.044–1.947]	0.349
Vascular emblus	Yes	42	0.042 [0.003–2.784]		0.077 [0.002–1.710]
pTNM stage	I-II	30	0.108 [0.004–4.554]	0.809	0.142 [0.024–1.742]	0.290
pTNM stage	III-IV	39	0.078 [0.007–4.686]		0.155 [0.008–1.947]
Depth of invasion	T₁₊₂	21	0.163 [0.009–11.008]	0.385	0.237 [0.024–1.748]	0.472
Depth of invasion	T₃₊₄	48	0.066 [0.004–3.004]		0.141 [0.009–1.890]
Lymh node metastasis	No	21	0.108 [0.004–6.230]	0.063	0.193 [0.026–1.749]	0.192
Lymh node metastasis	Yes	48	0.082 [0.005–4.276]		0.151 [0.009–1.890]
Distant metastasis	No	66	0.091 [0.005–5.148]	0.632	0.159 [0.010–1.808]	0.479
Distant metastasis	Yes	3	NI		NI

^* Mann–Whitney U -test: P<0.05; GC:Gastric Cancer; SM:Surgical Margin; NI:No information

ISSN: 1471-2407